Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
350 Results Found
AHA, others urge HRSA to extend timeline for comments and feedback on 340B pilot program
The AHA, joined by several other national groups representing 340B hospitals, Aug. 8 urged the Health Resources and Services Administration to extend the timeline for stakeholder comments, agency consideration and manufacturer rebate plan submissions for its 340B Rebate Model Pilot Program.
AHA 340B Advocacy Alliance Bulletin August 8, 2025
The AHA, joined by several other national groups representing 340B hospitals, today urged the Health Resources and Services Administration to extend the timeline for stakeholder comments, agency consideration, and manufacturer rebate plan submissions for its 340B Rebate Model Pilot Program.
AHA, Health Associations Comment on HRSA Notice of a 340B Rebate Model Pilot Program
AHA, health associations initial comment on the Health Resources and Services Administration’s (HRSA) notice of a 340B Rebate Model Pilot Program.
HRSA Issues Notice Establishing 340B Rebate Model Pilot Program
The Health Resources and Services Administration (HRSA) July 31 announced a 340B rebate model pilot program that will provide certain drugmakers the option to effectuate access to 340B discounted pricing for certain drugs under a rebate model.
340B Advocacy Alliance Bulletin - August 5, 2025
AHA Defends HHS Court Decision on 340B Rebate Model
AHA defends HHS decision to reject 340B rebate models by drug companies
The AHA today filed an amicus brief in the U.S.
AHA, Others Defend HHS Decision to Reject 340B Rebate Models by Drug Companies
ORAL ARGUMENT NOT YET SCHEDULEDNos. 25-5177, 25-5179, 25-5220, 25-5221, 25-5236
AHA 340B Advocacy Alliance Bulletin - AHA Regulatory Advisory on 340B Rebate Pilot Program
The Health Resources and Services Administration (HRSA) July 31 announced a 340B rebate model pilot program that will provide certain drugmakers the option to effectuate access to 340B discounted pricing for certain drugs under a rebate model.
HHS announces new 340B Rebate Model Pilot Program
The Department of Health and Human Services today issued a
AHA 340B Advocacy Alliance Newsletter
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug manufacturers to effectuate the 340B ceiling price on select drugs to all 340B covered entities.